SRRK250117P55000
- 13.30
- 0.000.00%
Scholar Rock Newsroom
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
AppLovin, MicroStrategy, and 28 Other Stocks That Could Be Bubbles
10 Health Care Stocks With Whale Alerts In Today's Session
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Scholar Rock(SRRK.US) 10% Shareholder Sells US$15.76 Million in Common Stock
Truist Financial Maintains Scholar Rock(SRRK.US) With Buy Rating, Maintains Target Price $45
Scholar Rock Price Target Raised to $45 From $36 at Truist
H.C. Wainwright Maintains Scholar Rock(SRRK.US) With Buy Rating, Raises Target Price to $50
Promising Market Dynamics and Growth Potential for Scholar Rock's Apitegromab Boost Buy Rating
HC Wainwright & Co. Maintains Buy on Scholar Rock Holding, Raises Price Target to $50
Express News | Scholar Rock Holding Corp : H.c. Wainwright Raises Target Price to $50 From $40
U.S. Small Caps Rise; Scholar Rock Holding Climbs Highest
12 Health Care Stocks Moving In Monday's Pre-Market Session
Sector Update: Health Care Stocks Advance Late Afternoon
Top Midday Gainers
Scholar Rock Hits 3-Year High on Rival Biohaven's Drug Setback
Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study
Biohaven Outcome 'Fundamental Net Positive' for Scholar Rock, Says JPMorgan
Express News | Corrected-Buzz-U.S. Stocks on the Move-AMC, Alnylam, Super Micro